Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2021

May 4, 2021

284_dirs_2021-05-04_89ecf544-ad1f-4bfe-a7ea-e9bc02bff8fa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2021-05-01

Reporting Person: LeCointe-Cephas Lisa (SVP Chief Ethics & Com Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-01 Common Stock M 622 $74.50 Acquired 1841.346 Direct
2021-05-01 Common Stock F 210 $74.50 Disposed 1631.346 Direct
2021-05-03 Common Stock M 437 $74.50 Acquired 2068.346 Direct
2021-05-03 Common Stock F 150 $74.50 Disposed 1918.346 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-05-01 Restricted Stock Unit $ M 622 Disposed 2023-05-01 Common Stock (622) Direct
2021-05-03 Restricted Stock Unit $ M 437 Disposed 2022-05-03 Common Stock (437) Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F3: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.

F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.